|[December 31, 2013]
Tyler Armstrong, 9, Summits Mt. Aconcagua and Raises Awareness to Benefit Cure Duchenne
NEWPORT BEACH, Calif. --(Business Wire)--
Nine-year-old Tyler Armstrong of Yorba Linda, Calif., became the
youngest person to summit Mt. Aconcagua in Argentina when he reached the
top of the 22,837 ft. mountain on Christmas Eve. Tyler climbed Mt.
Aconcagua to benefit CureDuchenne,
a nonprofit that raises awareness and funds research to find a cure for
Duchenne muscular dystrophy. Tyler arrives home from his adventure today.
"It was amazing to be on top of Mt. Aconcagua above the clouds with my
dad," said Tyler. "Some boys my age with Duchenne can't walk. I want the
world to know about Duchenne so they can find a cure. I want Duchenne
boys to have a chance to live."
Duchenne is a progressive muscle-wasting disease that impacts 1 in 3,500
boys. Boys are usually diagnosed by 5, in a wheelchair by 12 and most
don't survive their mid-20s. Tyler continues to fundraise for
CureDuchenne to support the most promising research projects aimed at
treating and curing Duchenne.
"We are so proud of Tyler for reaching the summit of Mt. Aconcagua on
behalf of CureDuchenne," said Debra Miller, founder and CEO of
CureDuchenne. "Tyler is a brave and compassionate boy like the boys and
young men who live with Duchenne every day. We are grateful that Tyler
has been able to reach new heights and help us raise awareness and money
to find a cure for Duchenne."
to donate to Tyler's climb and raise money to fund Duchenne research.
For more information on CureDuchenne, go to www.cureduchenne.org
or call 949-872-2552. Follow us on Facebook,
For more information on Tyler, visit: http://www.TopWithTyler.com
is a national nonprofit organization located in Newport Beach, Calif.,
dedicated to finding a cure for Duchenne, the most common and most
lethal form of muscular dystrophy. As the leading genetic killer of
young boys, Duchenne affects more than 300,000 boys worldwide.
CureDuchenne has garnered international attention for its efforts to
raise funds and awareness for Duchenne through venture philanthropy. To
date, seven CureDuchenne research projects have made their way into
human clinical trials - a unique accomplishment as few health-related
nonprofits have been successful in being a catalyst for human clinical
[ Back To Technology News's Homepage ]